| Neurological associations of COVID-19 MA Ellul, L Benjamin, B Singh, S Lant, BD Michael, A Easton, R Kneen, ... The Lancet Neurology 19 (9), 767-783, 2020 | 2460 | 2020 |
| Virology, epidemiology, pathogenesis, and control of enterovirus 71 T Solomon, P Lewthwaite, D Perera, MJ Cardosa, P McMinn, MH Ooi The Lancet infectious diseases 10 (11), 778-790, 2010 | 1663 | 2010 |
| Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study J Granerod, HE Ambrose, NWS Davies, JP Clewley, AL Walsh, D Morgan, ... The Lancet infectious diseases 10 (12), 835-844, 2010 | 1615 | 2010 |
| Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study A Varatharaj, N Thomas, MA Ellul, NWS Davies, TA Pollak, EL Tenorio, ... The Lancet Psychiatry 7 (10), 875-882, 2020 | 1607 | 2020 |
| Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination M Scully, D Singh, R Lown, A Poles, T Solomon, M Levi, D Goldblatt, ... New England Journal of Medicine 384 (23), 2202-2211, 2021 | 1095 | 2021 |
| Estimated global incidence of Japanese encephalitis: a systematic review GL Campbell, SL Hills, M Fischer, JA Jacobson, CH Hoke, JM Hombach, ... Bulletin of the World Health Organization 89 (10), 766-774, 2011 | 1087 | 2011 |
| Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score SR Knight, A Ho, R Pius, I Buchan, G Carson, TM Drake, J Dunning, ... bmj 370, 2020 | 1085 | 2020 |
| Pathogenic flaviviruses EA Gould, T Solomon The Lancet 371 (9611), 500-509, 2008 | 1049 | 2008 |
| Clinical features, diagnosis, and management of enterovirus 71 MH Ooi, SC Wong, P Lewthwaite, MJ Cardosa, T Solomon The Lancet Neurology 9 (11), 1097-1105, 2010 | 1033 | 2010 |
| SARS-CoV-2 Omicron-B. 1.1. 529 leads to widespread escape from neutralizing antibody responses W Dejnirattisai, J Huo, D Zhou, J Zahradník, P Supasa, C Liu, ... Cell 185 (3), 467-484. e15, 2022 | 974 | 2022 |
| Neurological manifestations of dengue infection T Solomon, NM Dung, DW Vaughn, R Kneen, B Raengsakulrach, ... The Lancet 355 (9209), 1053-1059, 2000 | 835 | 2000 |
| British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children G Thwaites, M Fisher, C Hemingway, G Scott, T Solomon, J Innes Journal of infection 59 (3), 167-187, 2009 | 807 | 2009 |
| Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 805 | 2021 |
| Japanese encephalitis T Solomon, NM Dung, R Kneen, M Gainsborough, DW Vaughn, VT Khanh Journal of Neurology, Neurosurgery & Psychiatry 68 (4), 405-415, 2000 | 712 | 2000 |
| Origin and evolution of Japanese encephalitis virus in southeast Asia T Solomon, H Ni, DWC Beasley, M Ekkelenkamp, MJ Cardosa, ... Journal of virology 77 (5), 3091-3098, 2003 | 675 | 2003 |
| Tick-borne encephalitis virus–a review of an emerging zoonosis KL Mansfield, N Johnson, LP Phipps, JR Stephenson, AR Fooks, ... Journal of General Virology 90 (8), 1781-1794, 2009 | 643 | 2009 |
| Acute management of dengue shock syndrome: a randomized double-blind comparison of 4 intravenous fluid regimens in the first hour NT Nhan, CXT Phuong, R Kneen, B Wills, N Van My, NTQ Phuong, ... Clinical Infectious Diseases 32 (2), 204-213, 2001 | 545 | 2001 |
| Management of suspected viral encephalitis in adults–association of British Neurologists and British Infection Association National Guidelines T Solomon, BD Michael, PE Smith, F Sanderson, NWS Davies, IJ Hart, ... Journal of infection 64 (4), 347-373, 2012 | 516* | 2012 |
| Flavivirus encephalitis T Solomon New England Journal of Medicine 351 (4), 370-378, 2004 | 496 | 2004 |
| Control of Japanese encephalitis—within our grasp? T Solomon New England Journal of Medicine 355 (9), 869-871, 2006 | 419 | 2006 |
